Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series

Leukemia and Lymphoma

Volumn 53, Issue 5, 2012, Pages 812-819

  Guisado Vasco, Pablo ^a   Arranz Saez, Reyes ^b   Canales, Miguel ^c   Cánovas, Araceli ^d   Garcia Laraña, José ^a   García Sanz, Ramón ^e   Lopez, Andrés ^f   López, José Luis ^g   Llanos, Marta ^h   Moraleda, José Maria ⁱ   Rodriguez, José ^j   Rayón, Consuelo ^k   Sabin, Pilar ^l   Salar, Antonio ^m   Marín Niebla, Ana ⁿ   Morente, Manuel ^o   Sánchez Godoy, Pedro ^p   Tomás, José Francisco ^q   Muriel, Alfonso ^a,r   Abraira, Victor ^a,r   Piris, Miguel A ^s   Garcia, Juán F ^o,q   Montalban, Carlos ^a   more..

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^h HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^m HOSPITAL DEL MAR   (Spain)

ⁿ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^o Centro Nacional de Investigaciones Oncológicas   (Spain)

^p HOSPITAL SEVERO OCHOA   (Spain)

^q MD ANDERSON CANCER CENTER   (Spain)

^r CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^s HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

more..

Author keywords

Hodgkin lymphoma; International Prognosis Score (IPS); outcome prediction

Indexed keywords

ALBUMIN; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HODGKIN DISEASE; HUMAN; INTERNATIONAL PROGNOSTIC SCORE; LEUKOCYTOSIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEX DIFFERENCE; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; HODGKIN DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859962776     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.635861     Document Type: Article

References (15)

1. Canellos GP, Anderson JR, Propert KJ, et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992;327:1478-1484.
2. S á nchez-Aguilera A, Montalb á n C, de la Cueva P, et al. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 2006;108:662-668. (Pubitemid 44061368)
3. S á nchez-Espiridon B, S á nchez-Aguilera A, Montalb á n C, et al. A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples. Clin Cancer Res 2009;15:1367-1375.
4. Sá nchez-Espiridión B, Montalb á n C, López A, et al. A molecular risk score based on four functional pathways for advanced classical Hodgkin lymphoma. Blood 2010;116:e12-e17.
5. M ontalbá n C, García JF, Abraira V, et al. Influence of biologic markers on the outcome of Hodgkin's lymphoma: a study by the Spanish Hodgkin's Lymphoma Study Group. J Clin Oncol 2004;22:1664-1673. (Pubitemid 41079805)
6. Alvaro T, Lejeune M, Salvado MT, et al. Outcome in Hodgkin' s lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005;11:1467-1473. (Pubitemid 40315228)
7. Morente MM, Piris MA, Abraira V, et al. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 1997;90:2429-2436. (Pubitemid 27392727)
8. Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classical Hodgkin's lymphoma. N Engl J Med 2010;362: 875-885.
9. Tzankov A, Meier C, Hirschmann P, et al. Correlation of high numbers of intratumoral FOXP3- regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 2008;93:193-200.
10. Kamper P, Bendix K, Hamilton-Dutoit S, et al. Tumor-infi ltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica 2011;96: 269-276.
11. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506-1514. (Pubitemid 28543499)
12. Hasenclever D. The disappearance of prognostic factors in Hodgkin' s disease. Ann Oncol 2002;13(Suppl. 1):75-78 (Pubitemid 34567405)
13. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
14. F ranklin J, Paulus U, Lieberz D, et al. Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? Ann Oncol 2000;11:617-623. (Pubitemid 30431388)
15. Moccia AA, Donaldson J, Chhanabhai M, et al. The International Prognostic Factor Project score (IPS) in advanced stage Hodgkin lymphoma has limited utility in patients treated in the modern era. Blood 2009;114(Suppl. 1): Abstract 1554.